Dexamethasone Dosage for Pediatric Croup

Introduction to Dexamethasone Treatment

• The American Academy of Pediatrics recommends a single stat dose of dexamethasone 0.6 mg/kg (maximum 16 mg) orally, intramuscularly, or intravenously for a 2-year-old child with croup 1

Dosing and Administration

• The standard dose is 0.6 mg/kg as a single stat dose, with a maximum cap of 16 mg regardless of weight, for children with croup 1
• For a typical 2-year-old weighing approximately 12-13 kg, the dose translates to 7.2-7.8 mg as a single dose 1
• All three routes (oral, IM, IV) are equally effective for croup treatment, with oral administration preferred when the child can tolerate it 1

Onset and Duration of Action

• The duration of action is 24-72 hours, providing sustained symptom relief from a single dose, without requiring tapering and without causing clinically significant adrenal suppression 1

Clinical Context and Adjunctive Therapy

• For severe croup presentations with prominent stridor, significant retractions, and agitation, consider adjunctive therapy with nebulized epinephrine (0.5 mL/kg of 1:1000 solution, maximum 5 mL) for more rapid symptom relief 2, 1
• Dexamethasone provides longer-lasting relief, while epinephrine provides immediate but short-term symptom improvement 1

Alternative Dosing for Other Conditions

• For bacterial meningitis (H. influenzae type b), the recommended dose is 0.15 mg/kg every 6 hours for 2-4 days, initiated 10-20 minutes prior to or concomitant with the first antimicrobial dose 3, 4, 5
• For tonsillectomy analgesia, at least 0.15 mg/kg shows analgesic benefit in children undergoing tonsillectomy 6

Critical Safety Considerations

• High-dose dexamethasone (0.5 mg/kg/day) for extended periods has been associated with adverse neurodevelopmental outcomes in preterm infants, including neuromotor dysfunction and growth impairment 7, 8, 9
• However, the single-dose regimen used for croup (0.6 mg/kg once) is fundamentally different from prolonged high-dose therapy and does not carry these same risks 1

Common Pitfalls to Avoid

• Do not use nebulized corticosteroids from hand-held inhalers with spacers—they are ineffective for croup 1
• Do not assume repeat dosing is necessary for all children with persistent symptoms; the single dose provides 24-72 hours of coverage 1
• For severe croup, do not delay treatment waiting to determine if the child can tolerate oral medication—intramuscular or intravenous routes are equally effective 1